Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bristol-Myers Squibb Company announced interim results from two Phase II studies of SPRYCEL (dasatinib) which demonstrate that the medicine may have potential as a treatment for a certain type of advanced prostate cancer.

Today in Other Drugs...keeping you current

Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation
Evidence-Based Medicine, 12/07/09

Treatment strategies for juvenile idiopathic arthritis
Expert Opinion in Pharmacotherapy, 12/07/09

Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address